SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-19-001259
Filing Date
2019-04-30
Accepted
2019-04-30 16:38:48
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 xeneticbioscience_10ka1.htm 10-K/A 215217
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10ka1-ex3103.htm EX-31.3 3734
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10ka1-ex3104.htm EX-31.4 3745
  Complete submission text file 0001683168-19-001259.txt   223896
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37937 | Film No.: 19782414
SIC: 2834 Pharmaceutical Preparations